Navigation Links
Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results
Date:8/10/2009

that the FDA may raise further issues regarding the BLA for KRYSTEXXA or require that we conduct additional clinical trials; our ability to commercialize and market acceptance of KRYSTEXXA; the delay or failure in completing development of KRYSTEXXA and developing other product candidates; our stock price and market conditions; varying interpretations of our clinical and CMC data by the FDA; delay achieving or failure to achieve FDA approval of KRYSTEXXA; inability to manufacture commercial quantities of our products; inability to gain market acceptance sufficient to justify development and commercialization costs if our products are approved for marketing; our continuing to incur substantial net losses for the foreseeable future; difficulties in obtaining financing; potential development of alternative or more effective products by competitors; reliance on third parties to manufacture, market and distribute many of our products; economic, political and other risks associated with foreign operations; risks of maintaining protection for our intellectual property; risks of an adverse determination in ongoing or future intellectual property litigation; and risks associated with stringent government regulation of the biopharmaceutical industry and other important factors set forth more fully in our reports filed with the Securities and Exchange Commission, to which investors are referred for further information. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements, which speak only as of the date of publication of this press release to shareholders. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investm
'/>"/>
SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th
2. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
3. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
4. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
5. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
6. Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015 Cocaine is an extreme stimulant, ... depression and hostility. In a joint effort between Australian ... of cocaine, may soon rejoice in what has been ... addictive biological response of cocaine, according to 7 ... researchers discovered that the brain is continually communicating with ...
(Date:2/27/2015)... February 27, 2015 Local lice removal service ... particularly in the areas of Pinecrest, Key Biscayne, Coral Gables, ... frustrated as they attempt to isolate and eradicate the problem. ... common “selfie” photograph may be partly to blame. As kids ... kind of head-to-head contact that can allow for the spread ...
(Date:2/27/2015)... RDI-Engineering will be hosting an educational ... on March 14, at Moreno Valley College. The station ... to use engineering software and tools, and a few ... Moreno Valley College’s Upward Bound Math and Science (UBMS) ... hopes to encourage students to seek educational and career ...
(Date:2/27/2015)... Prescription Drug “Take-Back” events are no ... (DEA). Today, local law enforcement in ... “Take-Back” guidelines for the proper disposal of controlled ... Drug Disposal Event , The McInstosh County Sheriff’s ... as the “Take-Back” site for the safe and ...
(Date:2/27/2015)... County, CO (PRWEB) February 27, 2015 Philanthropy ... Kevin and Amy Smits help to restore that ... for the last six years, this husband/wife Realtor team gives ... the charities have remained the same while others have been ... of Assault provides a safe haven and counseling for ...
Breaking Medicine News(10 mins):Health News:A New Study May Have an Answer to Treating Cocaine Addiction 2Health News:A New Study May Have an Answer to Treating Cocaine Addiction 3Health News:Parents frustrated as selfies continue to contribute to the spread of head lice in Miami according to the largest Lice Removal Service in Miami called Lice Troopers 2Health News:RDI-Engineering Participates in STEM”U”LATE Your Mind Event to Host Educational Exhibition 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 3Health News:Mr. And Mrs. Smits Proves That Altruism Works All Year Round 2
... Costs for Overburdened Justice Agencies , , WASHINGTON, June ... agencies, corporations, nonprofits and academic institutions are meeting today in ... mitigating what they call the crippling effects of alcohol misuse ... The third meeting for the National Partnership on ...
... , AUDUBON, Pa., June 2 Globus Medical, Inc., ... today announced the launch of the COALITION(TM) ACDF Spacer System. ... to provide the biomechanical strength of a traditional ACDF with ... , , The COALITION(TM) technology combines a PEEK ...
... release ,The Eat-Clean Diet For Men - Your Ironclad Plan to a ... LOS ANGELES, June 2 Tosca Reno , creator ... featured on entertainment news, daily syndicated TV show " EXTRA ... up your engine and boost your libido. , , ...
... University of Rochester , NY recently made the surprising discovery ... The researchers tracked 147 college graduates by investigating their goals ... were then evaluated again one year later. The study showed ... about the sense of happiness expected, but in many cases ...
... Medicine, Incorporated (RBM), the leading biomarker testing service, today ... Company as vice president, clinical diagnostics. Barnes will ... new biomarker-based diagnostic tests. , , ... improved drug development, has programs to develop new diagnostic ...
... 2 Express Scripts, Inc. (Nasdaq: ESRX ) ... shares of its common stock pursuant to an automatic shelf ... and Exchange Commission ("SEC"). The Company will grant the ... 3,450,000 additional shares of common stock to cover over-allotments, if ...
Cached Medicine News:Health News:National Partnership to Meet, Evaluate Addiction Treatment as Component of New Justice Programs 2Health News:National Partnership to Meet, Evaluate Addiction Treatment as Component of New Justice Programs 3Health News:Globus Medical Announces Launch of COALITION(TM) ACDF Spacer System 2Health News:EXTRA TV Features Tosca Reno's Eat-Clean Diet's Libido Boosting Foods 2Health News:Stress Expert Explains the Secret to True Happiness 2Health News:Rules-Based Medicine, Inc. Names Tony Barnes to Lead Expanding Diagnostics Business 2Health News:Express Scripts Launches Equity Offering to Finance Acquisition 2Health News:Express Scripts Launches Equity Offering to Finance Acquisition 3
(Date:2/26/2015)... , February 26, 2015 ... Outlook 2015: First -In- Class Innovations and Cost ... for Large Cap Pharmaceutical Companies research report to ... According to this Global Pharma US & ... as productivity measurements, divestment of non-core assets result ...
(Date:2/26/2015)... , Feb. 26, 2015  Spring Bank ... therapeutics for the treatment of Hepatitis B virus ... closing of a $22 million financing. Funds from ... 9200, a novel, broad spectrum antiviral agent derived ... acid hybrid (SMNH) chemistry platform, into Phase II ...
(Date:2/26/2015)... 26, 2015 Integrity Applications, Inc. (OTCQB: IGAP) ... model DF-F, a noninvasive  device that tracks blood glucose ... Ph.D., will head its new scientific advisory board that ... field of Diabetes research, monitoring and treatment. ... Chief Executive Officer and Head, Business Development of Profil ...
Breaking Medicine Technology:Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4Spring Bank Pharmaceuticals Completes $22 Million Financing 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 3Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 4
... , , ... Remedies announced today that its NutraRx brand of natural ... country to receive the Emerson EQP Seal in recognition of the ... "After a rigorous evaluation by Emerson Ecologics of our NutraRx brand ...
... ALBUQUERQUE, N.M. , Feb. 16 ... develops and markets proprietary genomic tests, today announced an ... promote its diagnostic services to gastroenterologists throughout the ... gastroenterology-focused sales force will introduce Exagen,s proprietary gene expression ...
Cached Medicine Technology:Native Remedies' NutraRx Brand of Natural Products for Medical Practitioners Among First to Earn Prestigious 'Emerson EQP Seal' 2Native Remedies' NutraRx Brand of Natural Products for Medical Practitioners Among First to Earn Prestigious 'Emerson EQP Seal' 3Exagen Diagnostics Enters Into Exclusive Agreement With EndoChoice 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: